Trusted Resources: Education
Scientific literature and patient education texts
Non-Liver Transplant Therapies for ATTR Amyloidosis 2022
source: Amyloidosis Support Groups
year: 2022
authors: Jeffrey Zonder
summary/abstract:Non-Liver Transplant Therapies for ATTR Amyloidosis 2022 lists different medications and therapies for treating ATTR Amyloidosis, a genetic disorder characterized by abnormal deposits of a protein called transthyretin (TTR). The table is divided into 3 categories: Tetramer Stabilizers, RNA-directed Therapies, and Gene Editing Therapies. Some of the therapies listed, such as Patisiran, Tafamidis, Inotersen, and Vutrisiran have FDA approval, while others are still in development.
read more
Related Content
-
Portland — Amyloidosis Support Groups Meeting — LIVE — Saturday, April 20, 2024When: Saturday, April 20, 2024 AL wi...
-
What Do All These Neurological Tests Mean? – ASG Webinar 6/7https://www.youtube.com/watch?v=IzC_yaqs...
-
Wild-Type Transthyretin Cardiac Amyloidosis – Mayo Clinichttps://www.youtube.com/watch?v=RnWxzRD1...
-
Chafic Karam, MDDr. Chafic Karam is a Neurologist at the...
-
Symptom Mangement in Cardiac Amyloidosis: Back to Basics – ASG Webinar 3/11https://www.youtube.com/watch?v=K2TmwAfu...
-
Landmark CRISPR Trial Shows Promise Against Deadly DiseasePreliminary results from a landmark clin...
-
Features of Atrial Fibrillation in Wild-Type Transthyretin Cardiac Amyloidosis: A Systematic Review and Clinical Exp...Aims: Wild-type transthyretin (ATTRwt) ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.